9月3日，瑞慈医疗（01526.HK）于2026年9月3日向香港交易及结算所有限公司提交截至2026年8月31日止月份的证券变动月报表。
2026年8月31日，公司以每股0.8318港元回购11000股普通股并持作库存股份，相关回购授权经2026年6月17日股东大会通过。回购后，已发行股份（不包括库存股份）由15.88亿股减少至15.88亿股，库存股份由275万股增加至276.1万股，已发行股份总数维持15.9亿股不变。
法定/注册股本未发生变动，仍为100亿股，面值每股0.0001美元，总额100万美元。公司确认已符合适用的公众持股量最低门槛要求。两项股份期权计划本月内均未发生行使、注销或失效变动。报表由董事方宜新呈交。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.